The percentage of patients with a thyroid nodule fine needle aspiration (FNA) diagnosis by cytology of Bethesda category 3 or 4 with a recommendation for molecular testing in Final Pathology Report, followed with direct communication to Patient/Ordering or Attending Provider regarding recommendation.